Bill Miller - Miller Value Partners,
Holding/activity history for Alexion Pharmaceuticals Inc (ALXN)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2020 Q1 | 0 | 0.00 | Sell 100.00% | 1.51 | SEC | ||
| 2019 Q4 | 388,380 | 1.51 | Reduce 13.46% | 0.24 | $108.15 | $42,003,000 | SEC |
| 2019 Q3 | 448,780 | 1.79 | $97.94 | $43,954,000 | SEC | ||
| 2019 Q2 | 448,780 | 2.23 | Add 0.25% | <0.01 | $130.98 | $58,781,000 | SEC |
| 2019 Q1 | 447,680 | 2.42 | Reduce 0.10% | <0.01 | $135.18 | $60,517,000 | SEC |
| 2018 Q4 | 448,135 | 2.00 | Reduce 0.15% | <0.01 | $97.36 | $43,630,000 | SEC |
| 2018 Q3 | 448,825 | 2.05 | Add 1.46% | 0.03 | $139.01 | $62,391,000 | SEC |
| 2018 Q2 | 442,345 | 2.21 | Add 5.05% | 0.11 | $124.15 | $54,917,000 | SEC |
| 2018 Q1 | 421,065 | 2.11 | Reduce 3.62% | 0.09 | $111.46 | $46,932,000 | SEC |
| 2017 Q4 | 436,865 | 2.44 | Reduce 1.70% | 0.05 | $119.59 | $52,245,000 | SEC |
| 2017 Q3 | 444,425 | 2.95 | Reduce 1.40% | 0.03 | $140.29 | $62,348,000 | SEC |
| 2017 Q2 | 450,725 | 2.43 | Add 25.66% | 0.50 | $121.67 | $54,840,000 | SEC |
| 2017 Q1 | 358,700 | 2.48 | Add 259.74% | 1.79 | $121.24 | $43,489,000 | SEC |
| 2016 Q4 | 99,710 | 0.73 | Buy | 0.73 | $122.35 | $12,200,000 | SEC |